A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden

Journal of Internal Medicine

Volumn 278, Issue 4, 2015, Pages 335-353

  Feltelius, N ^a   Persson, I ^a   Ahlqvist Rastad, J ^a   Andersson, M ^a   Arnheim Dahlstrom L ^b   Bergman, P ^c   Granath, F ^b   Adori, C ^b   Hokfelt T ^b   Kuhlmann Berenzon S ^d   Liljestrom P ^b   Maeurer, M ^b   Olsson, T ^b   Ortqvist A ^b,e   Partinen, M ^f,g   Salmonson, T ^a   Zethelius, B ^a  

^a MEDICAL PRODUCTS AGENCY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^e STOCKHOLM COUNTY COUNCIL   (Sweden)

^f Vitalmed Research Centre   (Finland)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adverse events; Influenza; Narcolepsy; Sweden; Vaccination

Indexed keywords

EPITOPE; GAMMA INTERFERON; HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE; INTERFERON GAMMA (1-39); PEPTIDE FRAGMENT;

ALLELE; ANTIGEN RECOGNITION; GENE; GENETIC ANALYSIS; HLA DQB1 GENE; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFLUENZA A (H1N1); MEDICAL RESEARCH; NARCOLEPSY; PRIORITY JOURNAL; REVIEW; SWEDEN; VACCINATION; ADOLESCENT; ADVERSE EFFECTS; BIOSYNTHESIS; CHILD; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; PUBLIC RELATIONS; RESEARCH; STREPTOCOCCUS;

ADOLESCENT; CHILD; EPITOPES; HEMAGGLUTININS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; INTERPROFESSIONAL RELATIONS; NARCOLEPSY; NEURAMINIDASE; PEPTIDE FRAGMENTS; RESEARCH; STREPTOCOCCUS; SWEDEN; VACCINATION;

EID: 84941025668     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12391     Document Type: Review

References (47)

1. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007; 369: 499-511.
2. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95: 322-7.
3. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-85.
4. Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014; 13: 600-13.
5. Hallböök T, Szakacs A, Bialek F, Feltelius N, Landtblom A, Malmgren K. Narkolepsi - ovanlig sjukdom som fått ökad uppmärksamhet. Läkartidningen 2014; 111: CZFX.
6. Jacob L, Leib R, Ollila HM, Bonvalet M, Adams CM, Mignot E. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Brain Behav Immun 2015; 47: 44-57.
7. Vaarala O, Vuorela A, Partinen M, et al. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk. PLoS One 2014; 9: e114361.
8. Montplaisir J, Petit D, Quinn MJ, et al. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One 2014; 9: e108489.
9. European Centre for Disease Prevention and Control. Narcolepsy in Association with Pandemic Influenza Vaccination. A Multicountry European Epidemiological Investigation. Technical Report. Stockholm: ECDC, 2012.
10. Olsson T. Patogenes, genetik och immunologi. Information fran Lakemedelsverket 2013; 24: 20-3.
11. Bomfim IL, Kockum I, Arnheim-Dahlström L et al. The immunogenetics in context of a defined environmental trigger in form of post-pandemrix associated narcolepsy mimics spontaneous disease, submitted.
12. Bomfim IL, Fink K, Lamb F, et al. Genetic study of Pandemrix-associated narcolepsy. J Neuroimmunol 2014; 275: 50-1.
13. Persson I, Granath F, Askling J, Ludvigsson JF, Olsson T, Feltelius N. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med 2014; 275: 172-90.
14. Han F, Lin L, Warby SC, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011; 70: 410-7.
15. Bergman P, Adori C, Vas S, et al. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci USA 2014; 111: E3735-44.
16. van den Pol AN, Acuna-Goycolea C, Clark KR, Ghosh PK. Physiological properties of hypothalamic MCH neurons identified with selective expression of reporter gene after recombinant virus infection. Neuron 2004; 42: 635-52.
17. Rao Y, Lu M, Ge F, et al. Regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus. J Neurosci 2008; 28: 9101-10.
18. Ahnaou A, Drinkenburg WH, Bouwknecht JA, Alcazar J, Steckler T, Dautzenberg FM. Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep-wake architecture. Eur J Pharmacol 2008; 579: 177-88.
19. Konadhode RR, Pelluru D, Blanco-Centurion C, et al. Optogenetic stimulation of MCH neurons increases sleep. J Neurosci 2013; 33: 10257-63.
20. Chung S, Parks GS, Lee C, Civelli O. Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists. J Mol Neurosci 2011; 43: 115-21.
21. Nilsson IA, Lindfors C, Schalling M, Hokfelt T, Johansen JE. Anorexia and hypothalamic degeneration. Vitam Horm 2013; 92: 27-60.
22. Poli F, Pizza F, Mignot E, et al. High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep 2013; 36: 175-81.
23. Inocente CO, Gustin MP, Lavault S, et al. Quality of life in children with narcolepsy. CNS Neurosci Ther 2014; 20: 763-71.
24. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009; 41: 708-11.
25. Han F, Lin L, Li J, et al. HLA-DQ association and allele competition in Chinese narcolepsy. Tissue Antigens 2012; 80: 328-35.
26. Kornum BR, Kawashima M, Faraco J, et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011; 43: 66-71.
27. Hinze-Selch D, Wetter TC, Zhang Y, et al. In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls. Neurology 1998; 50: 1149-52.
28. Okun ML, Giese S, Lin L, Einen M, Mignot E, Coussons-Read ME. Exploring the cytokine and endocrine involvement in narcolepsy. Brain Behav Immun 2004; 18: 326-32.
29. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001; 68: 686-99.
30. Ambati A, Meng Q, Poiret T, et al. Increased Influenza specific IFN-γ production in HLA DQB1*06:02-positive Pandemrix® vaccinated individuals, in manuscript.
31. Ambati A, Poiret T, Svahn BM, et al. Increased β-haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases. J Intern Med 2015; doi: 10.1111/joim.12355 [E-pub ahead of print].
32. ®-vaccination. Immunology 2015; 145: 357-366.
33. MPA. A registry based comparative cohort study in four Swedish counties of the risk for narcolepsy after vaccination with Pandemrix - a first and preliminary report, by the Medical Products Agency. www.mpa.se. 2011.
34. MPA. Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations - results of a case inventory study by the MPA in Sweden during 2009-2010. www.mpa.se. 2011.
35. Kühlmann-Berenzon S, Linde A. Internal commissioned report by the Swedish Institute for Infectious Disease Control. The higher incidence of vaccine-related narcolepsy cases in the South of Sweden still unexplained. Results from an ecological study on the possible association between the circulation of influenza A(H1N1)pdm09, narcolepsy and Pandemrix vaccination in Sweden, submitted.
36. Arnheim-Dahlström L. Infections, Vaccinations and Narcolepsy - A Case-Control Study in Sweden. Regulatory report. 2014. Available on request from the MPA, Uppsala, Sweden.
37. Socialstyrelsen (The National Board of Health and Welfare Sweden). Patientregistret. Available at: http://www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish [accessed 25 February 2015].
38. Statistics Sweden. The Swedish register of education. Available at: http://www.scb.se/statistik/UF/UF0506/Produktbeskrivning_short_English_UF0506_20040101r.doc [accessed 25 February 2015].
39. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic and Coding Manual. Chicago, IL: AASM, 2005.
40. Bonhoeffer J, Kohl K, Chen R, et al. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine 2002; 21: 298-302.
41. Freimuth VS, Musa D, Hilyard K, Quinn SC, Kim K. Trust during the early stages of the 2009 H1N1 pandemic. J Health Commun 2014; 19: 321-39.
42. Picchioni D, Hope CR, Harsh JR. A case-control study of the environmental risk factors for narcolepsy. Neuroepidemiology 2007; 29: 185-92.
43. European Centre for Disease Prevention and Control. Communication on Immunisation - Building Trust. Stockholm: ECDC. 2012; doi: 10.2900/20590.
44. Centre hospitalier et Universitaire de Bordeaux, INSERM, Université Bordeaux Segalen, France. NarcoFlu-FV study: influenza, influenza vaccination and narcolepsy: French contribution to the European case control study. August 6, 2012. Etude NarcoFlu-VF (NarcoFlu VAESCO-France): Grippe, vaccination antigrippale et narcolepsie: contribution française à l'étude cas-témoins européenne. Août 2012. (20/09/2012) (1854 ko).
45. Miller E, Andrews N, Stellitano L et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 2013; 346: f794.
46. Department of Health, Ireland. Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010. Final report of the Narcolepsy Study Steering Committee. April 19, 2012. Available at: http://www.dohc.ie/publications/Nat_Narcolespy_Study_SC_Report.html. [accessed April 2012].
47. Heier MS, Gautvik KM, Wannag E et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med 2013; 14: 867-71.